1 / 34

Lymphoma s

Lymphoma s. S. Sami Kartı, MD, Prof. Conceptualizing lymphoma. neoplasms of lymphoid origin, typically causing lymphadenopathy. ALL. CLL. Lymphomas. MM. Neutrophils. AML. Myeloproliferative disorders. Myeloid progenitor. Eosinophils. Hematopoietic stem cell. Basophils. Monocytes.

bayard
Download Presentation

Lymphoma s

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Lymphomas S. Sami Kartı, MD, Prof.

  2. Conceptualizing lymphoma • neoplasms of lymphoid origin, typically causing lymphadenopathy

  3. ALL CLL Lymphomas MM Neutrophils AML Myeloproliferative disorders Myeloid progenitor Eosinophils Hematopoietic stem cell Basophils Monocytes Platelets Red cells naïve germinal center B-lymphocytes Plasma cells Lymphoid progenitor T-lymphocytes

  4. CLL MM ALL DLBCL, FL, HL B-cell development memory B-cell germinal center B-cell stem cell mature naive B-cell lymphoid progenitor progenitor-B pre-B immature B-cell plasma cell Bone marrow Lymphoid tissue

  5. Biologically rational classification Clinically useful classification • Diseases that have distinct • morphology • immunophenotype • genetic features • clinical features • Diseases that have distinct • clinical features • natural history • prognosis • treatment Classification

  6. Lymphoma classification(2001 WHO) • B-cell neoplasms • precursor • mature • T-cell & NK-cell neoplasms • precursor • mature • Hodgkin lymphoma Non- Hodgkin Lymphomas

  7. Category Survival of untreated patients Curability To treat or not to treat Non-Hodgkin lymphoma Indolent Years Generally not curable Generally defer Rx if asymptomatic Aggressive Months Curable in some Treat Very aggressive Weeks Curable in some Treat Hodgkin lymphoma All types Variable – months to years Curable in most Treat A practical way to think of lymphoma

  8. Mechanisms of lymphomagenesis • Genetic alterations • Infection • Antigen stimulation • Immunosuppression

  9. Epidemiology of lymphomas • 5th most frequently diagnosed cancer in both sexes • males > females • incidence • NHL increasing • Hodgkin lymphoma stable

  10. Risk factors for NHL • immunosuppression or immunodeficiency • connective tissue disease • family history of lymphoma • infectious agents • ionizing radiation

  11. Clinical manifestations • Variable • severity: asymptomatic to extremely ill • time course: evolution over weeks, months, or years • Systemic manifestations • fever, night sweats, weight loss, anorexia, pruritis • Local manifestations • lymphadenopathy, splenomegaly most common • any tissue potentially can be infiltrated

  12. Other complications of lymphoma • bone marrow failure (infiltration) • CNS infiltration • immune hemolysis or thrombocytopenia • compression of structures (eg spinal cord, ureters) • pleural/pericardial effusions, ascites

  13. Diagnosis requires an adequate biopsy • Diagnosis should be biopsy-proven before treatment is initiated • Need enough tissue to assess cells and architecture • open bx vs core needle bx vs FNA

  14. Stage I Stage II Stage III Stage IV Staging of lymphoma A: absence of B symptoms B: fever, night sweats, weight loss

  15. Three common lymphomas • Diffuse large B-cell lymphoma • Follicular lymphoma • Hodgkin lymphoma

  16. Relative frequencies of different lymphomas Non-Hodgkin Lymphomas Diffuse large B-cell Hodgkin lymphoma NHL Follicular Other NHL ~85% of NHL are B-lineage

  17. Follicular lymphoma • most common type of “indolent” lymphoma • usually widespread at presentation • often asymptomatic • not curable (some exceptions) • associated with BCL-2 gene rearrangement [t(14;18)] • cell of origin: germinal center B-cell

  18. defer treatment if asymptomatic (“watch-and-wait”) • several chemotherapy options if symptomatic • median survival: years • despite “indolent” label, morbidity and mortality can be considerable • transformation to aggressive lymphoma can occur

  19. Diffuse large B-cell lymphoma

  20. Introduction • most common type of “aggressive” lymphoma • extranodal involvement is common • cell of origin: germinal center B-cell

  21. Clinical presentation • Usually presents with one or more rapidly growing tumor masses involving nodal or extranodal sites • Not tender • Usually not interfere organ function except by compression

  22. Treatment • Chemotherapy • Radiotherapy • Chemotherapy + radiotherapy • Autologous or allogeneic stem cell transplantation in relaps or refractory cases

  23. Hodgkin lymphoma Thomas Hodgkin (1798-1866)

  24. Classical Hodgkin Lymphoma

  25. Hodgkin lymphoma • cell of origin: germinal centre B-cell • Reed-Sternberg cells (or RS variants) in the affected tissues • most cells in affected lymph node are polyclonal reactive lymphoid cells, not neoplastic cells

  26. Reed-Sternberg cell

  27. RS cell and variants classic RS cell lacunar cell popcorn cell

  28. A possible model of pathogenesis loss of apoptosis transforming event(s) EBV? cytokines germinal centre B cell RS cell inflammatory response

  29. Histologic subtypes • Classical Hodgkin lymphoma • nodular sclerosis (most common subtype) • mixed cellularity • lymphocyte-rich • lymphocyte depleted

  30. Epidemiology • less frequent than non-Hodgkin lymphoma • overall M>F • peak incidence in 3rd decade

  31. Associated (etiological?) factors • EBV infection • smaller family size • higher socio-economic status • caucasian > non-caucasian • possible genetic predisposition • other: HIV? occupation? herbicides?

  32. Clinical manifestations • lymphadenopathy • extranodal sites relatively uncommon except in advanced disease • “B” symptoms

  33. Treatment and Prognosis

  34. Long term complications of treatment • infertility • MOPP > ABVD; males > females • sperm banking should be discussed • premature menopause • secondary malignancy • skin, AML, lung, MDS, NHL, thyroid, breast... • cardiac disease

More Related